FI973591A0 - Nya syntetiserade kryptofysiner - Google Patents

Nya syntetiserade kryptofysiner

Info

Publication number
FI973591A0
FI973591A0 FI973591A FI973591A FI973591A0 FI 973591 A0 FI973591 A0 FI 973591A0 FI 973591 A FI973591 A FI 973591A FI 973591 A FI973591 A FI 973591A FI 973591 A0 FI973591 A0 FI 973591A0
Authority
FI
Finland
Prior art keywords
cryptophysers
new synthesis
synthesis
new
Prior art date
Application number
FI973591A
Other languages
English (en)
Finnish (fi)
Inventor
Richard E Moore
Marcus A Tius
Russell A Barrow
Jian Liang
Thomas H Corbett
Frederick A Valeriote
Thomas K Hemscheidt
Original Assignee
Univ Hawaii
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/400,057 external-priority patent/US6013626A/en
Priority claimed from US08/482,141 external-priority patent/US5952298A/en
Application filed by Univ Hawaii, Univ Wayne State filed Critical Univ Hawaii
Publication of FI973591A0 publication Critical patent/FI973591A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI973591A 1995-03-07 1997-09-03 Nya syntetiserade kryptofysiner FI973591A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/400,057 US6013626A (en) 1993-12-21 1995-03-07 Cryptophycins from synthesis
US08/482,141 US5952298A (en) 1993-12-21 1995-06-07 Cryptophycins
PCT/US1996/003246 WO1996040184A1 (en) 1995-03-07 1996-03-07 New cryptophycins from synthesis

Publications (1)

Publication Number Publication Date
FI973591A0 true FI973591A0 (fi) 1997-09-03

Family

ID=27016884

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973591A FI973591A0 (fi) 1995-03-07 1997-09-03 Nya syntetiserade kryptofysiner

Country Status (23)

Country Link
EP (1) EP0830136B1 (ro)
JP (1) JP4181632B2 (ro)
CN (1) CN1165337C (ro)
AP (1) AP737A (ro)
AT (1) ATE279935T1 (ro)
AU (1) AU723652B2 (ro)
BG (1) BG63289B1 (ro)
CZ (1) CZ278197A3 (ro)
DE (1) DE69633667T2 (ro)
ES (1) ES2230561T3 (ro)
FI (1) FI973591A0 (ro)
GE (1) GEP20002206B (ro)
HK (1) HK1009747A1 (ro)
HU (1) HU225041B1 (ro)
MD (1) MD2196B2 (ro)
NO (1) NO326685B1 (ro)
NZ (1) NZ305571A (ro)
OA (1) OA10614A (ro)
PL (1) PL185949B1 (ro)
RO (1) RO118931B1 (ro)
SK (1) SK119997A3 (ro)
TJ (1) TJ347B (ro)
WO (1) WO1996040184A1 (ro)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007798A1 (en) * 1995-08-30 1997-03-06 Eli Lilly And Company Pharmaceutical compounds
CA2264294A1 (en) * 1996-08-30 1998-03-05 University Of Hawai'i Process for preparing pharmaceutical compounds
ES2267149T3 (es) * 1996-08-30 2007-03-01 University Of Hawaii Nuevos derivados de criptoficina como agentes antineoplasicos.
US6680311B1 (en) 1996-08-30 2004-01-20 Eli Lilly And Company Cryptophycin compounds
JP2001500496A (ja) * 1996-09-06 2001-01-16 イーライ・リリー・アンド・カンパニー 医薬化合物の製造方法
CA2263764A1 (en) * 1996-09-06 1998-03-12 Michael John Martinelli Process and novel intermediates
HUP0000212A3 (en) * 1996-09-06 2001-12-28 Wayne State University Detroit Process to prepare cryptophycin derivatives and intermediates thereof
CA2281104A1 (en) * 1997-02-26 1998-09-03 University Of Hawaii Selective epoxidation process for preparing pharmaceutical compounds
JP2001513775A (ja) * 1997-02-26 2001-09-04 イーライ・リリー・アンド・カンパニー トリペプチドおよびテトラペプチド医薬化合物
EP0870506A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
EP0870510A3 (en) * 1997-04-11 1999-09-15 Eli Lilly And Company Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents
EP0870501A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections
US6376230B1 (en) 1998-10-16 2002-04-23 Eli Lilly And Company Stereoselective process for producing intermediates of cryptophycins
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
BR9916051A (pt) * 1998-10-16 2001-08-14 Lilly Co Eli Processo estereosseletivo para produzir agentes antineoplásticos
AU1930100A (en) * 1998-12-07 2000-06-26 Eli Lilly And Company Crotylboration process to produce cryptophycin compounds
US6372936B1 (en) * 1999-06-09 2002-04-16 Eli Lilly And Company Optical resolution of aminoisobobutyric acid
FR2947269B1 (fr) 2009-06-29 2013-01-18 Sanofi Aventis Nouveaux composes anticancereux

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4868208A (en) * 1988-07-15 1989-09-19 Merck & Co., Inc. Antifungal agent and method
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
WO1995017093A1 (en) * 1993-12-21 1995-06-29 University Of Hawaii New cryptophycins

Also Published As

Publication number Publication date
TJ347B (en) 2002-10-06
JPH11510476A (ja) 1999-09-14
EP0830136A4 (en) 2001-01-24
DE69633667D1 (en) 2004-11-25
GEP20002206B (en) 2000-08-25
BG63289B1 (bg) 2001-09-28
HK1009747A1 (en) 1999-06-11
MD2196B2 (ro) 2003-06-30
NO326685B1 (no) 2009-01-26
SK119997A3 (en) 1998-12-02
BG101875A (en) 1998-10-30
ES2230561T3 (es) 2005-05-01
AU5360396A (en) 1996-12-30
NO974105D0 (no) 1997-09-05
OA10614A (en) 2001-03-15
HU225041B1 (en) 2006-05-29
AP737A (en) 1999-03-15
MD970313A (ro) 1999-06-30
CZ278197A3 (cs) 1998-12-16
PL185949B1 (pl) 2003-09-30
EP0830136B1 (en) 2004-10-20
CN1165337C (zh) 2004-09-08
NZ305571A (en) 1999-02-25
CN1183726A (zh) 1998-06-03
HUP9801880A3 (en) 1999-08-30
AP9701069A0 (en) 1997-10-30
AU723652B2 (en) 2000-08-31
DE69633667T2 (de) 2006-03-02
NO974105L (no) 1997-11-05
WO1996040184A1 (en) 1996-12-19
ATE279935T1 (de) 2004-11-15
RO118931B1 (ro) 2004-01-30
PL322507A1 (en) 1998-02-02
EP0830136A1 (en) 1998-03-25
HUP9801880A2 (hu) 1998-11-30
JP4181632B2 (ja) 2008-11-19

Similar Documents

Publication Publication Date Title
FI972970A0 (fi) Uusia yhdisteitä
NO982850D0 (no) Ny syntese
NO20001950D0 (no) Syntese av SAPO-44
DE69620399D1 (de) Sprachsynthese
FI20030162A (fi) Uusia yhdisteitä
DE69607536T2 (de) Estersynthese
LV11178A (lv) 3-Ú4-(2-aminoetoksi) benzoil¾-2-aril-6-hidroksibenzoÚb¾tiofenu sintezes panemiens
NO974701D0 (no) Syntese av tale-bölgeformer
MX199501B (es) Sintesis asimetrica de (-)6-cloro-4-ciclopropiletinil-4-trifluorometil-1,4-dihidro-2h-3,1-benzoxazin-2-ona
DE69711667D1 (de) Gensyntheseverfahren
FI973591A0 (fi) Nya syntetiserade kryptofysiner
DK0805790T3 (da) Forbedret syntese af cyclopropylacetylen
BR9611475A (pt) 5-aminoisotiaz is acilados
NO20005187D0 (no) n-sats syntese av 2-oksazolidinonderivater
NO990832D0 (no) Syntese av bisendolylmalimider
IT1295934B1 (it) Procedimento migliorato per la sintesi di alchilpoliglucosidi
NO20001896D0 (no) Fremgangsmõte for syntese av klorpurinmellomprodukter
DE69603578D1 (de) Synthese von tetrafluorethylen
EE9900420A (et) Kõnesünteesi juurde kuuluv meetod
BR9708718A (pt) Sínteses de aminas substituídas
FI962592A0 (fi) Uudet välituotteet keinotekoisina makeutusaineina käyttökelpoisten L-aspartyyli-D-alfa-aminoalkanoyyli-(S)-N-alfa-alkyylibentsyyliamidien syntetisoimiseksi
DE69707656T2 (de) Synthese von cycloalkyldiarylphosphin
IT1286527B1 (it) Procedimento per la sintesi di 2-idrossi-4-alchilossi benzofenone
DE69708273T2 (de) Synthese von cycloalkyldiarylphosphin
KR970011853U (ko) 새로운 형태의 메리야스

Legal Events

Date Code Title Description
FA Application withdrawn [patent]